What revenues and/or EPS do your models put you at? And is it that you think their multiple on those figures is too high? I get a billion in revenue in 2020 and think it justifies a 20billion mkt cap for this high hype industry.
Really can't disagree with your short position because I don't see much for catalysts to make a run in the next couple months. There's always the unforeseen PR that can throw a wrench in that but until rec sales start I don't think we bump up and it's been a concern of mine what the reported sales a couple months after weed hits the shelves will do to the valuation. It has to be justified at some point in time and that should be at the least the first full quarter sales report.